RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Quality & Compliance: An NDA for Water

Quality & Compliance: An NDA for Water

Posted 01 February 2008

This is a case study about the requirement of a New Drug Application (NDA) for water as the active pharmaceutical ingredient (API) of an eyewash product. It is an ongoing case, representing an unforeseen glitch in the regulations. Most of the information is public but I will not name the company.


© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.